The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services PHS, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2006. 35. US Office of the Surgeon General. Reducing the Health Consequences of Smoking: 25 Years of Progress: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services PHS; 1989:89 8411. 36. Isles C, Brown JJ, Cumming AM, Lever AF, McAreavey D, Robertson JI, Hawthorne VM, Stewart GM, Robertson JW, Wapshaw J. Excess smoking in malignant-phase hypertension. BMJ. 1979;1:579 581. 37. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE; Lung Health Study Research Group. The effects of a smoking cessa- tion intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005;142:233 239. 38. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999 2008. JAMA. 2010;303:235 241. 39. Chiang BN, Perlman LV, Epstein FH. Overweight and hypertension: a review. Circulation. 1969;39:403 421. 40. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523 1529. 41. Wilson PW, D Agostino RB, Sullivan L, Parise H, KannelWB. Overweight and obesity as determinants of cardiovascular risk: the Framingham expe- rience. Arch Intern Med. 2002;162:1867 1872. 42. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76 79. 43. Kotchen TA. Obesity-related hypertension: epidemiology, pathophysiol- ogy, and clinical management. Am J Hypertens. 2010;23:1170 1178. 44. 